Redbiotec competitorsClear all

Redbiotec's top competitors include Neogene Therapeutics, Empirica Therapeutics, Cytonus Therapeutics and Epify.

Save Comparison	Redbiotec Redbiotec is a biotech company that develops immunotherapies for cancer and herpes.	Neogene Therapeutics Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.	Empirica Therapeutics Empirica Therapeutics is a company developing immunotherapies to treat cancers.	Cytonus Therapeutics Cytonus Therapeutics is a company specializing in immune-oncology and gene therapies.	Epify Epify is a company developing epigenetic biomarkers that control gene activity.
Founding Date	Founding Date 2006	Founding Date 2018	Founding Date 2018	Founding Date 2018	Founding Date 2019
Type	Type Private	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech genetics oncology therapy	Tags Healthcare biotech genetics oncology therapy	Tags Healthcare biotech genetics oncology therapy	Tags Healthcare biotech genetics oncology therapy	Tags Healthcare biotech genetics oncology therapy
Locations	Locations Schlieren, CH HQ	Locations New York, US HQ Amsterdam, NL	Locations Hamilton, CA HQ	Locations HQ	Locations Maastricht, NL HQ
Employees	Employees 16	Employees 254% increase	Employees 260% decrease	Employees 2	Employees 525% increase
Twitter followers	Twitter followers 117	Twitter followers N/A	Twitter followers 31	Twitter followers 168	Twitter followers 19
Number of tweets (last 30 days)	Number of tweets (last 30 days) 3	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 9	Number of tweets (last 30 days) N/A
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 1.7	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 0.2	Average likes per tweet (last 30 days) N/A
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 33.33%	Percentage of tweets with engagement (last 30 days) N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 110m (4 months ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 548.8k (over 1 year ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 110m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 548.8k